Skip to main content
Clinical Trials/NCT03218579
NCT03218579
Unknown
Not Applicable

Endoscopic Assessment and Prediction of Microbiome-modifying Interventions

Tel-Aviv Sourasky Medical Center1 site in 1 country45 target enrollmentFebruary 1, 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gut Microbiome
Sponsor
Tel-Aviv Sourasky Medical Center
Enrollment
45
Locations
1
Primary Endpoint
Microbiome composition
Last Updated
8 years ago

Overview

Brief Summary

The investigators would like to examine the extent of gut microbiome rehabilitation in healthy people after the consumption of antibiotics.

Outcomes of probiotic treatment versus bacteriotherapy will be compared.

Detailed Description

The investigators would like to examine the extent of rehabilitation of the composition and functioning of the intestinal bacteria in healthy people after the consumption of antibiotics. Since the digestive mocus enables the connection between the host and the bacteria that live within it, the investigators would like to characterize the microbiome in the different areas along the digestive system - before antibiotic treatment and after rehabilitation by probiotic treatment versus bacteriotherapy.

Registry
clinicaltrials.gov
Start Date
February 1, 2013
End Date
December 30, 2020
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Healthy volunteers
  • Age: 18 years and up
  • Gender: women and men

Exclusion Criteria

  • Pregnancy
  • Age under 18 years
  • antibiotic treatment 3 months prior to enrollment
  • Viral Hepatitis
  • HIV positive

Outcomes

Primary Outcomes

Microbiome composition

Time Frame: 1 year

stool samples

Secondary Outcomes

  • Microbiome composition(1 month)

Study Sites (1)

Loading locations...

Similar Trials